An FDA panel voted to keep GlaxoSmithKline's diabetes drug Avandia on the market despite heart risks http://on.wsj.com/dzpyHW
1:32 PM - 14 Jul 2010
0 replies
13 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.